Postoperative Dexmedetomidine in Prevention of Postoperative Delirium

NACompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

November 11, 2023

Primary Completion Date

March 6, 2024

Study Completion Date

April 28, 2024

Conditions
Delirium in Old AgeAnesthesia; Adverse Effect
Interventions
DRUG

Dexmedetomidine injection

Combining with 3 μg.kg-1 sufentanil, 3 μg.kg-1 dexmedetomidine is injected through intravenous patient controlled anesthesia pump in a 2 ml bolus with 20 minutes lock-out, and a background infusion rate of 2 ml per hour.

DRUG

Sufentanil injection

3 μg.kg-1 sufentanil is injected through intravenous patient controlled anesthesia pump in a 2 ml bolus with 20 minutes lock-out, and a background infusion rate of 2 ml per hour.

Trial Locations (1)

650100

Kunming Children's Hospital, Kunming

All Listed Sponsors
collaborator

Shenzhen People's Hospital

OTHER

collaborator

Dongyuan People's Hospital

UNKNOWN

collaborator

Kunming Children's Hospital

OTHER

lead

Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.

INDUSTRY

NCT06382961 - Postoperative Dexmedetomidine in Prevention of Postoperative Delirium | Biotech Hunter | Biotech Hunter